United States (US) Transdermal Scopolamine Patch Market (2025-2031) | Segmentation, Industry, Trends, Analysis, Competitive Landscape, Value, Share, Forecast, Outlook, Size & Revenue, Growth, Companies

Market Forecast By Type (1mg, 1.5mg), By Application (Motion Sickness, Nausea/Vomiting, Parkinsonian Tremor, Others) And Competitive Landscape
Product Code: ETC9978343 Publication Date: Sep 2024 Updated Date: Nov 2025 Product Type: Market Research Report
Publisher: 6Wresearch Author: Vasudha No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

United States (US) Transdermal Scopolamine Patch Market Top 5 Importing Countries and Market Competition (HHI) Analysis

The United States continues to rely on imports of transdermal scopolamine patches, with top exporting countries in 2024 being Israel, Belgium, Japan, Sweden, and Denmark. The Herfindahl-Hirschman Index (HHI) for these shipments saw a significant decrease from very low to low concentration from 2023 to 2024. The compound annual growth rate (CAGR) for the period 2020-2024 was -21.67%, with a steep decline in growth rate from 2023 to 2024 at -59.13%. This data suggests a shift in the dynamics of transdermal scopolamine patch imports into the US market.

United States (US) Transdermal Scopolamine Patch Market Top 5 Importing Countries and Market Competition (HHI) Analysis

Key Highlights of the Report:

  • United States (US) Transdermal Scopolamine Patch Market Outlook
  • Market Size of United States (US) Transdermal Scopolamine Patch Market, 2024
  • Forecast of United States (US) Transdermal Scopolamine Patch Market, 2031
  • Historical Data and Forecast of United States (US) Transdermal Scopolamine Patch Revenues & Volume for the Period 2021- 2031
  • United States (US) Transdermal Scopolamine Patch Market Trend Evolution
  • United States (US) Transdermal Scopolamine Patch Market Drivers and Challenges
  • United States (US) Transdermal Scopolamine Patch Price Trends
  • United States (US) Transdermal Scopolamine Patch Porter's Five Forces
  • United States (US) Transdermal Scopolamine Patch Industry Life Cycle
  • Historical Data and Forecast of United States (US) Transdermal Scopolamine Patch Market Revenues & Volume By Type for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Transdermal Scopolamine Patch Market Revenues & Volume By 1mg for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Transdermal Scopolamine Patch Market Revenues & Volume By 1.5mg for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Transdermal Scopolamine Patch Market Revenues & Volume By Application for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Transdermal Scopolamine Patch Market Revenues & Volume By Motion Sickness for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Transdermal Scopolamine Patch Market Revenues & Volume By Nausea/Vomiting for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Transdermal Scopolamine Patch Market Revenues & Volume By Parkinsonian Tremor for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Transdermal Scopolamine Patch Market Revenues & Volume By Others for the Period 2021- 2031
  • United States (US) Transdermal Scopolamine Patch Import Export Trade Statistics
  • Market Opportunity Assessment By Type
  • Market Opportunity Assessment By Application
  • United States (US) Transdermal Scopolamine Patch Top Companies Market Share
  • United States (US) Transdermal Scopolamine Patch Competitive Benchmarking By Technical and Operational Parameters
  • United States (US) Transdermal Scopolamine Patch Company Profiles
  • United States (US) Transdermal Scopolamine Patch Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the United States (US) Transdermal Scopolamine Patch Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United States (US) Transdermal Scopolamine Patch Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Transdermal Scopolamine Patch Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Transdermal Scopolamine Patch Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Transdermal Scopolamine Patch Market - Industry Life Cycle

3.4 United States (US) Transdermal Scopolamine Patch Market - Porter's Five Forces

3.5 United States (US) Transdermal Scopolamine Patch Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 United States (US) Transdermal Scopolamine Patch Market Revenues & Volume Share, By Application, 2021 & 2031F

4 United States (US) Transdermal Scopolamine Patch Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of motion sickness and postoperative nausea and vomiting

4.2.2 Growing demand for non-invasive drug delivery methods

4.2.3 Rising adoption of transdermal patches for convenient and continuous drug delivery

4.3 Market Restraints

4.3.1 Stringent regulations and approval processes for transdermal scopolamine patches

4.3.2 Potential side effects and skin irritations associated with transdermal patch usage

4.3.3 Competition from alternative forms of antiemetic medications

5 United States (US) Transdermal Scopolamine Patch Market Trends

6 United States (US) Transdermal Scopolamine Patch Market, By Types

6.1 United States (US) Transdermal Scopolamine Patch Market, By Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Transdermal Scopolamine Patch Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 United States (US) Transdermal Scopolamine Patch Market Revenues & Volume, By 1mg, 2021- 2031F

6.1.4 United States (US) Transdermal Scopolamine Patch Market Revenues & Volume, By 1.5mg, 2021- 2031F

6.2 United States (US) Transdermal Scopolamine Patch Market, By Application

6.2.1 Overview and Analysis

6.2.2 United States (US) Transdermal Scopolamine Patch Market Revenues & Volume, By Motion Sickness, 2021- 2031F

6.2.3 United States (US) Transdermal Scopolamine Patch Market Revenues & Volume, By Nausea/Vomiting, 2021- 2031F

6.2.4 United States (US) Transdermal Scopolamine Patch Market Revenues & Volume, By Parkinsonian Tremor, 2021- 2031F

6.2.5 United States (US) Transdermal Scopolamine Patch Market Revenues & Volume, By Others, 2021- 2031F

7 United States (US) Transdermal Scopolamine Patch Market Import-Export Trade Statistics

7.1 United States (US) Transdermal Scopolamine Patch Market Export to Major Countries

7.2 United States (US) Transdermal Scopolamine Patch Market Imports from Major Countries

8 United States (US) Transdermal Scopolamine Patch Market Key Performance Indicators

8.1 Patient compliance rate with transdermal scopolamine patch therapy

8.2 Number of clinical trials evaluating the efficacy and safety of transdermal scopolamine patches

8.3 Adoption rate of transdermal patches in the overall antiemetic market

9 United States (US) Transdermal Scopolamine Patch Market - Opportunity Assessment

9.1 United States (US) Transdermal Scopolamine Patch Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 United States (US) Transdermal Scopolamine Patch Market Opportunity Assessment, By Application, 2021 & 2031F

10 United States (US) Transdermal Scopolamine Patch Market - Competitive Landscape

10.1 United States (US) Transdermal Scopolamine Patch Market Revenue Share, By Companies, 2024

10.2 United States (US) Transdermal Scopolamine Patch Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Related Reports

Industry Events and Analyst Meet

Whitepaper

Read All